![](/img/cover-not-exists.png)
Cost analysis of ganirelix versus luteal-phase lupron downregulation per assisted reproductive technology (ART) cycle and pregnancy achieved
R.L. Gustofson, J.H. Segars, F.W. LarsenVolume:
82
Year:
2004
Language:
english
DOI:
10.1016/j.fertnstert.2004.07.301
File:
PDF, 161 KB
english, 2004